For years, one of the most powerful weapons against certain blood cancers, called CAR-T cell therapy, has required an ...
The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies.
Morning Overview on MSN
Japan approves first treatment made from reprogrammed human cells
Japan’s health ministry has endorsed two stem-cell therapies derived from induced pluripotent stem (iPS) cells, making them the first treatments of their kind to clear a national regulatory body ...
Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, which are infection and tumor-fighting white blood cells, so that they have a ...
The reprogramming of glutamine metabolism holds a pivotal position in the energy provision and biosynthesis of tumors. However, the regulatory mechanism of this phenomenon in non-small cell lung ...
Atomic defects in nanodiamonds enable both precise heating of lysosomes inside macrophages and nanoscale temperature measurement, revealing that localized thermal spikes trigger immune cell ...
The low efficiency of somatic cell nuclear transfer (SCNT) severely limits its application in animal cloning and regenerative medicine. To address this core scientific challenge, this study aims to ...
New funding led by Goldcrest Capital and Godfrey Capital to advance lead candidate JUN_01 for type 2 diabetes and obesity to first-in-human studies JUN_01 would be the first ever candidate to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results